ERBB2 and breast cancer: In another classification system currently used by pathologists, several biomarkers frequently observed in breast cancer are used, including estrogen receptor (ER), progesterone receptor (PR), receptor tyrosine-protein kinase erbB-2 (HER2/neu), and p53.